Appendix B
Workshop Agenda
FEBRUARY 28, 2022
9:30 a.m. | Welcome from the National Cancer Policy Forum |
Planning Committee Co-Chairs: | |
|
|
9:40 a.m. | Session 1: Overview of the Use of EHRs in Oncology Care, Research, and Surveillance |
Co-moderators: | |
|
|
Session Objective: To review the current state and trends of EHRs and discuss the evidence base for the design, development, and use of EHRs in cancer care, research, and surveillance. | |
Technical and Contextual Evolution of EHRs | |
Mia Levy, Foundation Medicine, Inc. |
The Electronic Health Record: From the View of the Oncologist | |
Lawrence N. Shulman, University of Pennsylvania Abramson Cancer Center | |
Facilitator of Trust or Mediator of Communication: The EHR and the Patient–Physician Relationship | |
Gwen Darien, National Patient Advocate Foundation | |
Integrating Social Determinants of Health in EHRs: Ethical and Social Justice Issues | |
Chanita Hughes-Halbert, USC Norris Comprehensive Cancer Center | |
Quality Improvement and Research Perspective | |
Neal J. Meropol, Flatiron Health | |
Panel Discussion with Speakers | |
11:10 a.m. | Break |
11:20 a.m. | Session 2: Opportunities to Improve the Patient-Facing Aspects of EHRs |
Co-moderators: | |
|
|
Session Objective: To explore opportunities and approaches to improve the patient-facing aspects of EHRs to empower patients and improve patient care and outcomes. | |
The Impact of EHRs on the Physician–Patient Relationship | |
Jyoti D. Patel, Northwestern University | |
Integrating Patient-Reported Outcomes into Electronic Health Record Systems in Oncology | |
Ethan Basch, University of North Carolina at Chapel Hill | |
Today’s Patient Portal and Sharing of Patient Data across EHR Systems for Cancer Care and Research | |
Travis J. Osterman, Vanderbilt University Medical Center |
Using the EHR to “Nudge” Evidence-Based Cancer Care | |
Samuel U. Takvorian, Penn Medicine | |
Next-Generation EHRs to Facilitate Oncology Care | |
George Hripcsak, Columbia University | |
Panel Discussion with Speakers | |
12:50 p.m. | Lunch Break |
1:50 p.m. | Session 3: Opportunities to Optimize the Functionality and Usability of EHRs in Oncology Care |
Co-moderators: | |
|
|
Session Objective: To examine the challenges and opportunities to optimize the functionality and usability of EHRs in clinical workflow to meet the needs of the various users in oncology care. | |
Oncology Care Pathways: Importance and Relation to Current EHRs’ Functionality and Opportunities for Improvement | |
Robin Zon, Michiana Hematology Oncology | |
Opportunities for Decision Support through the Use of EHRs | |
Mary M. Ichiuji, Kaiser Permanente | |
Efficiency of EHR Use and Management in Creating an Ideal Workspace and Presentation of Critical Data for Oncology-Specific Care Providers | |
Shilo Anders, Vanderbilt University | |
Interface between Electronic Systems and Humans: View from Outside of Medicine | |
Elizabeth Mynatt, Northeastern University | |
Human Factors Engineering for EHR Design in Oncology Care: The Patient Experience across the Cancer Care Continuum | |
Pascale Carayon, University of Wisconsin-Madison |
An Industry Perspective | |
Jenna Date, Allscripts Hospital and Health Systems | |
Panel Discussion with Speakers | |
3:25 p.m. | Break |
3:35 p.m. | Session 4: Roundtable—Innovative Strategies to Improve EHR Data Collection to Support Care Quality and Research Initiatives |
Co-moderators: | |
|
|
Session Objective: To discuss new approaches and opportunities to enhance EHR structure, data collection and standardization, interoperability, and EHR integration to improve clinical care and enhance oncology research. | |
Clinician Perspective | |
Tufia C. Haddad, Mayo Clinic College of Medicine and Sciences | |
Opportunities and Challenges: Entry of Critical Structured Data into EHRs | |
Monica Bertagnolli, Brigham and Women’s Hospital and Dana-Farber Cancer Institute | |
Researcher Perspective: Opportunities for Improved Research | |
Jeremy L. Warner, Vanderbilt University | |
Quality Improvement Initiatives: Opportunities for Improved Quality of Care | |
Barry Russo, The Center for Cancer and Blood Disorders | |
Payer Perspective | |
Reed V. Tuckson, Black Coalition Against COVID and Tuckson Health Connections, LLC | |
Panel Discussion with Panelists |
4:50 p.m. | Closing Remarks |
5:00 p.m. | Adjourn |
MARCH 1, 2022
9:00 a.m. | Welcome and Overview of Day 2 |
Planning Committee Co-Chairs | |
|
|
9:05 a.m. | Session 5: The Roles of Federal Agencies to Advance Progress in EHRs |
Co-moderators: | |
|
|
Session Objective: To explore current collaborations and initiatives to conceptualize and implement innovations in EHRs and discuss potential policy incentives for the adoption of improved EHRs in cancer care, research, and surveillance. | |
Potential Role of Science and Technology Policy in Advancement of EHRs | |
Bich-Thuy (Twee) Sim, Office of Science and Technology Policy and the Department of Defense | |
Advancing Progress in EHRs: Cancer Surveillance as an Example | |
Lynne Penberthy, National Cancer Institute | |
Electronic Health Records for Public Health Planning and Research | |
Lisa C. Richardson, Centers for Disease Control and Prevention |
Leveraging Electronic Health Records: Expanding Opportunities for Evidence Generation | |
Paul G. Kluetz, Oncology Center of Excellence, Food and Drug Administration | |
Ready, Set, Go!: Leveraging EHRs for Innovation | |
Avinash Shanbhag, Office of Technology, Office of the National Coordinator | |
CMMI Perspective | |
Lara Strawbridge, Center for Medicare and Medicaid Innovation, Centers for Medicare & Medicaid Services | |
Panel Discussion with Speakers | |
10:35 a.m. | Break |
10:45 a.m. | Session 6: Policies to Foster EHR Redesign to Advance Progress in Cancer Care, Research, and Surveillance |
Co-moderators: | |
|
|
Session Objective: To discuss potential policy levers and actionable strategies to enhance innovation in the development, implementation, and use of EHRs in oncology care, research, and surveillance. | |
Panelists (Session Co-moderators) | |
|
|
Open Discussion | |
11:50 a.m. | Closing Remarks |
Mia Levy, Foundation Medicine, Inc. | |
Planning Committee Co-Chair | |
12:00 p.m. | Adjourn |